Industry Verticals »

All Categories

Insights »

About TMR »

Influenza Diagnostics Market

Influenza Diagnostics Market (Test Type: RT-PCR Tests, Rapid Influenza Diagnostic Tests, Viral Culture, Immunofluorescence Assays, Serological Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Global Influenza Diagnostics Market Outlook 2036

  • The industry was valued at US$ 1.9 Bn in 2025
  • It is projected to grow at a CAGR of 6.0% from 2026 to 2036 and reach more than US$ 3.7 Bn by the end of 2036

Influenza Diagnostics Market By Region

Analyst Viewpoint

Increase in prevalence and incidence of influenza is driving the global influenza diagnostics market. Persistent threat of seasonal and pandemic influenza outbreaks has been witnessed in the past few years. The global impact of influenza on public health has prompted substantial investments in research & development. Government initiatives aimed at influenza surveillance and outbreak control are the major factors propelling market development. Furthermore, rise in demand for rapid diagnostic tests is expected to bolster the global influenza diagnostics industry size during the forecast period.

Technological advancements and introduction of innovative diagnostic tools offer lucrative opportunities to market players. Manufacturers are focusing on developing user-friendly, portable, and cost-effective diagnostic devices in order to increase market share.

Global Influenza Diagnostics Market Overview

Influenza, commonly known as the flu, is a highly contagious respiratory infection caused by influenza viruses. The impact of influenza on global public health underscores the importance of effective diagnostics for timely and accurate identification of the virus.

Influenza viruses belong to the Orthomyxoviridae family and are classified into types A, B, C, and D. Among these, influenza A and B are the predominant types responsible for seasonal outbreaks and pandemics.

Accurate and rapid influenza diagnostics play a crucial role in patient management, infection control, and public health surveillance. Various diagnostic methods are employed, ranging from traditional laboratory techniques such as viral culture and serological assays to more modern molecular techniques such as polymerase chain reaction (PCR) and rapid antigen tests.

Molecular methods offer high sensitivity and specificity, enabling the detection of viral RNA or DNA within hours, whereas rapid antigen tests provide quick results but may have lower sensitivity.

Rise in Prevalence and Incidence of Influenza

In the past few years, the global landscape has witnessed a notable surge in the occurrence of influenza, a contagious respiratory infection caused by influenza viruses. This upswing is multifactorial, influenced by various environmental, demographic, and virological factors. High transmission rates, compounded by the evolving nature of influenza viruses, underscore the pressing need for accurate and timely diagnostics. This in turn is fueling the global influenza diagnostics market.

Surge in prevalence of influenza can be ascribed to several factors, including increased globalization, urbanization, and population density. As individuals interact more frequently and over longer distances, the transmission of influenza viruses becomes more efficient.

Rapid urbanization has led to densely populated areas, creating environments conducive to rapid viral spread. These demographic shifts contribute significantly to the increasing burden of influenza on a global scale.

According to the World Health Organization, globally, there are around one billion cases of seasonal influenza annually, with 3 million to 5 million severe cases and 290,000 to 650,000 respiratory deaths. Thus, high disease burden fuels demand for efficient and accurate diagnostic tools.

The U.S. Centers for Disease Control and Prevention (CDC) reported early increase in influenza activity during the 2022-2023 season, particularly among children and adolescents. Hospitalization rates were also higher than in previous years.

The dynamic nature of influenza viruses, characterized by frequent mutations and antigenic drift, further exacerbates the challenge. This continual evolution enables the virus to evade immune responses, rendering previously exposed populations susceptible to reinfection. Consequently, demand for robust diagnostic tools becomes imperative for effective disease management and public health interventions.

In the realm of healthcare, the escalating prevalence of influenza is directly correlated with the rise in incidence of severe respiratory complications, hospitalizations, and mortality. This places a substantial burden on healthcare systems globally, necessitating swift and accurate diagnostic solutions to streamline patient management and implement appropriate preventive measures. This escalating prevalence and incidence of influenza is fueling the global influenza diagnostics market growth.

Increase in Demand for Rapid Diagnostic Tests

Surge in demand for Rapid Diagnostic Tests (RDTs) has emerged as a major factor propelling the global influenza diagnostics market demand. The ascendancy of RDTs as a primary diagnostic tool signifies a paradigm shift in influenza diagnostics, redefining the landscape with its inherent advantages. This escalating demand is underpinned by the urgent need for swift and accurate diagnostic outcomes, reflecting a discernible departure from conventional methodologies.

The prominence of RDTs can be ascribed to expeditious results, offering a real-time assessment of influenza infection status. This immediacy is imperative for timely clinical decision-making and initiation of appropriate therapeutic interventions.

Fast-paced lifestyles and the constant need for rapid responses in healthcare settings have increased preference for RDTs, positioning them as indispensable tools in influenza diagnostics.

Moreover, rise in demand for RDTs is intricately linked to their user-friendly nature, which facilitates decentralized testing. The accessibility of RDTs outside traditional laboratory settings ensures that diagnostic capabilities are extended to diverse healthcare settings, including remote and resource-constrained areas. This decentralization is pivotal in enhancing diagnostic reach and efficacy, particularly during influenza outbreaks or pandemics.

Cost-effectiveness of RDTs has further fueled adoption, aligning with the economic considerations of healthcare providers and patients alike. The overall reduction in turnaround time and the concomitant economic benefits associated with rapid diagnostics amplify the attractiveness of RDTs in the influenza diagnostics landscape. Thus, increase in demand for rapid diagnostic tests is likely to bolster the global influenza diagnostics market value.

Rapid Turnaround Time & Exceptional Accuracy Propelling Demand for RT-PCR Tests

In terms of test type, the RT-PCR tests segment accounted for the largest global influenza diagnostics market share in 2025. RT-PCR boasts exceptional accuracy, detecting even trace amounts of viral RNA within hours. This rapid turnaround time (TAT) allows for prompt diagnosis and initiation of targeted treatment, improving patient outcomes and curbing transmission.

RT-PCR's ability to differentiate between influenza A and B subtypes is crucial for appropriate antiviral therapy and public health interventions. RT-PCR assays are readily scalable, adapting to high testing demands during outbreaks. Additionally, automation minimizes human error and increases throughput, crucial for managing large-scale testing needs.

Recognizing RT-PCR's advantages, governments worldwide are actively promoting its adoption. India's Integrated Disease Surveillance Programme (IDSP) emphasizes RT-PCR as the primary influenza diagnostic tool. This nationwide push fosters infrastructure development and trained personnel, further solidifying RT-PCR's dominance.

A 2020 study by the Centers for Disease Control and Prevention (CDC) found that RT-PCR had a 98.7% sensitivity and 99.5% specificity for influenza A and B detection, compared to 78.1% and 96.6% for rapid influenza diagnostic tests (RIDTs).

Regional Outlook

As per influenza diagnostics market analysis, North America dominated the global industry in 2025. This is ascribed to high disease burden, advanced healthcare infrastructure, stringent regulations, robust public health surveillance, and a supportive private and public sector landscape.

The U.S., with an average of 13.5 million annual influenza cases, bears the brunt of the disease in the region. Well-equipped hospitals and laboratories, coupled with widespread adoption of electronic health records, facilitate the use of sophisticated diagnostic tools such as molecular assays and rapid influenza diagnostic tests (RIDTs).

According to influenza diagnostics market forecast, the industry in Asia Pacific is projected to grow at a rapid pace during the forecast period. This is ascribed to rise in influenza burden, increase in healthcare awareness, expanding diagnostic options, aging population, and proactive government initiatives.

This growth trajectory holds immense potential for further development and innovation in influenza diagnostics within the region, ultimately contributing to improved public health outcomes.

Key Players in Global Influenza Diagnostics Industry

Leading players in the global market have adopted strategies such as mergers & acquisitions, strategic collaborations, and new product launches to expand presence and gain market share.

3M, Abbott, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Goldsite Diagnostics, Inc., Hologic, Inc., DiaSorin S.p.A., Meridian Bioscience, Inc., QuidelOrtho Corporation, SA Scientific Ltd., Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific are the prominent players in the global influenza diagnostics market.

Key Developments in Global Influenza Diagnostics Market

  • In 2025, Thermo Fisher Scientific continued expansion of its respiratory testing capabilities through multiplex molecular assay solutions, supporting simultaneous detection of influenza and other respiratory pathogens. The increasing integration of multiplex PCR platforms is improving diagnostic efficiency by reducing the need for separate tests during seasonal respiratory outbreaks.
  • In June 2024, Roche received U.S. FDA Emergency Use Authorization (EUA) for the cobas® Influenza A/B & RSV nucleic acid test, designed for use on the cobas liat system. The multiplex molecular assay enables detection and differentiation of influenza A, influenza B, and respiratory syncytial virus (RSV) from a single nasal swab sample, delivering results in approximately 20 minutes. The launch strengthened the adoption of rapid molecular point-of-care respiratory testing solutions.
  • In 2024-2025, QuidelOrtho expanded its Sofia® respiratory diagnostic portfolio, including enhanced antigen-based testing solutions for influenza and COVID-19. These developments supported increased adoption of decentralized testing platforms by enabling rapid results at physician offices, urgent care centers, and point-of-care settings.
  • In 2024, Abbott expanded its molecular respiratory diagnostics portfolio with multiplex testing solutions capable of detecting influenza A, influenza B, RSV, and COVID-19 from a single sample. The growing availability of multiplex respiratory panels reflects the shift from single-pathogen influenza testing toward broader syndromic testing approaches, particularly in hospitals and emergency care settings.

The influenza diagnostics market report profiles the top players based on various factors including company overview, financial summary, strategies, product portfolio, segments, and recent advancements.

Global Influenza Diagnostics Market Snapshot

Attribute Detail
Size in 2025 US$ 1.9 Bn
Forecast (Value) in 2036 US$ 3.7 Bn
Growth Rate (CAGR) 6.0%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2025)
  • Company profiles section includes an overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation Flu Virus Type
  • Type A
  • Type B
Test Type
  • RT-PCR Tests
  • Rapid Influenza Diagnostic Tests (RIDTs)
  • Viral Culture
  • Immunofluorescence Assays
  • Serological Tests
  • Others (LAMP, SAMBA, etc.)
Product Type
  • Kits & Reagents
  • Instruments
  • Others
End-user
  • Hospitals
  • Diagnostic Centers
  • Others (academics & research institutes, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • 3M
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • BIOMÉRIEUX
  • Bio-Rad Laboratories, Inc.
  • Goldsite Diagnostics, Inc.
  • Hologic, Inc.
  • DiaSorin S.p.A.
  • Meridian Bioscience, Inc.
  • QuidelOrtho Corporation
  • SA Scientific Ltd.
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Other Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global influenza diagnostics market in 2025?

It was valued at US$ 1.9 Bn in 2025

How big will the influenza diagnostics business be in 2036?

It is projected to reach more than US$ 3.7 Bn by 2036

What will be the CAGR of the influenza diagnostics industry during the forecast period?

The CAGR is anticipated to be 6.0% from 2026 to 2036

Which influenza diagnostics segment held significant share in 2025?

The RT-PCR tests segment accounted for the largest share in 2025

Which region will account for major share of the influenza diagnostics sector during the forecast period?

North America is anticipated to account for the leading share during the forecast period.

Who are the prominent influenza diagnostics manufacturers?

3M, Abbott, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Goldsite Diagnostics, Inc., Hologic, Inc., DiaSorin S.p.A., Meridian Bioscience, Inc., QuidelOrtho Corporation, SA Scientific Ltd., Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific among others.

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Influenza Diagnostics Market
  4. Market Overview
    • Introduction
      • Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Influenza Diagnostics Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Mn)
  5. Key Insights
    • Disease Epidemiology
    • Reimbursement Scenario
    • Technological Advancements
  6. Global Influenza Diagnostics Market Analysis and Forecast, by Flu Virus Type
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Attractiveness Analysis, by Flu Virus Type
  7. Global Influenza Diagnostics Market Analysis and Forecast, by Test Type
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Attractiveness Analysis, by Test Type
  8. Global Influenza Diagnostics Market Analysis and Forecast, by Product Type
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Attractiveness Analysis, by Product Type
  9. Global Influenza Diagnostics Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Attractiveness Analysis, by End-user
  10. Global Influenza Diagnostics Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  11. North America Influenza Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Value Forecast, by Country, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Flu Virus Type
      • By Test Type
      • By Product Type
      • By End-user
      • By Country
  12. Europe Influenza Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Flu Virus Type
      • By Test Type
      • By Product Type
      • By End-user
      • By Country/Sub-region
  13. Asia Pacific Influenza Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Flu Virus Type
      • By Test Type
      • By Product Type
      • By End-user
      • By Country/Sub-region
  14. Latin America Influenza Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Flu Virus Type
      • By Test Type
      • By Product Type
      • By End-user
      • By Country/Sub-region
  15. Middle East & Africa Influenza Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Flu Virus Type, 2021-2036
      • Type A
      • Type B
    • Market Value Forecast, by Test Type, 2021-2036
      • RT-PCR Tests
      • Rapid Influenza Diagnostic Tests (RIDTs)
      • Viral Culture
      • Immunofluorescence Assays
      • Serological Tests
      • Others (LAMP, SAMBA, etc.)
    • Market Value Forecast, by Product Type, 2021-2036
      • Kits & Reagents
      • Instrument
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Centers
      • Others (academics & research institutes, etc.)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Flu Virus Type
      • By Test Type
      • By Product Type
      • By End-user
      • By Country/Sub-region
  16. Competition Landscape
    • Market Player - Competition Matrix (by tier and size of companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • 3M
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Abbott
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • F. Hoffmann-La Roche Ltd.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Becton, Dickinson and Company
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • BIOMÉRIEUX
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Bio-Rad Laboratories, Inc.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Goldsite Diagnostics Inc.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Hologic, Inc.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • DiaSorin S.p.A.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Meridian Bioscience, Inc.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • QuidelOrtho Corporation
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • SA Scientific Ltd.
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Sekisui Diagnostics
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Siemens Healthineers
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview
      • Thermo Fisher Scientific
        • Company Overview (HQ, Business Segments, Employee Strength)
        • Product Portfolio
        • Financial Overview
        • SWOT Analysis
        • Strategic Overview

List of Tables

Table 01: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 02: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 03: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 04: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 05: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Region, 2021 to 2036
Table 06: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country, 2021 to 2036
Table 07: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 08: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 09: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 10: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 11: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 12: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 13: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 14: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 15: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 16: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 17: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 18: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 19: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 20: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 21: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 22: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 23: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 24: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 25: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 26: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 27: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2021 to 2036
Table 28: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2021 to 2036
Table 29: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 30: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Influenza Diagnostics Market Size, by Flu Virus Type, 2025
Figure 02: Global Influenza Diagnostics Market Share (%), by Flu Virus Type, 2025
Figure 03: Global Influenza Diagnostics Market Size, by Test Type, 2025
Figure 04: Global Influenza Diagnostics Market Share (%), by Test Type, 2025
Figure 05: Global Influenza Diagnostics Market Size, by Product Type, 2025
Figure 06: Global Influenza Diagnostics Market Share (%), by Product Type, 2025
Figure 07: Global Influenza Diagnostics Market Size, by End-user, 2025
Figure 08: Global Influenza Diagnostics Market Share (%), by End-user, 2025
Figure 09: Global Influenza Diagnostics Market, by Region (2025 and 2036)
Figure 10: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 11: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 12: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025
Figure 13: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2036
Figure 14: Global Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 15: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 16: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025
Figure 17: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2036
Figure 18: Global Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 19: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 20: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025
Figure 21: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2036
Figure 22: Global Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 23: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 24: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025
Figure 25: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2036
Figure 26: Global Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 27: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2025 and 2036
Figure 28: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2025
Figure 29: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2036
Figure 30: Global Influenza Diagnostics Market Attractiveness Analysis, by Region, 2026 to 2036
Figure 31: North America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2036
Figure 32: North America Influenza Diagnostics Market Value Share Analysis, by Country, 2025 and 2036
Figure 33: North America Influenza Diagnostics Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 34: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 35: North America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 36: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 37: North America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 38: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 39: North America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 40: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 41: North America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 42: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2036
Figure 43: Europe Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 44: Europe Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 45: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 46: Europe Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 47: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 48: Europe Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 49: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 50: Europe Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 51: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 52: Europe Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 53: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2036
Figure 54: Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 55: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 56: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 57: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 58: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 59: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 60: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 61: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 62: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 63: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 64: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2036
Figure 65: Latin America Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 66: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 67: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 68: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 69: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 70: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 71: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 72: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 73: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 74: Latin America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 75: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2036
Figure 76: Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 77: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 78: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2025 and 2036
Figure 79: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2026 to 2036
Figure 80: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2025 and 2036
Figure 81: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2026 to 2036
Figure 82: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2025 and 2036
Figure 83: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 84: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2025 and 2036
Figure 85: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Influenza Diagnostics Market

Buy This ReportBuy Now